VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3163
ETF rank
โ‚ฌ13.5 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
18,25ย โ‚ฌ
Share price
-0.14%
Change (1 day)
-7.77%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of February 2026: 0.35%